292 related articles for article (PubMed ID: 32655564)
1. The Superior Ability of Human BDCA3
Gu FF; Zhang K; Ma LL; Liu YY; Li C; Hu Y; Yang QF; Liang JY; Zeng YL; Wang Y; Liu L
Front Immunol; 2020; 11():1267. PubMed ID: 32655564
[TBL] [Abstract][Full Text] [Related]
2. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
Jongbloed SL; Kassianos AJ; McDonald KJ; Clark GJ; Ju X; Angel CE; Chen CJ; Dunbar PR; Wadley RB; Jeet V; Vulink AJ; Hart DN; Radford KJ
J Exp Med; 2010 Jun; 207(6):1247-60. PubMed ID: 20479116
[TBL] [Abstract][Full Text] [Related]
3. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.
Schreibelt G; Klinkenberg LJ; Cruz LJ; Tacken PJ; Tel J; Kreutz M; Adema GJ; Brown GD; Figdor CG; de Vries IJ
Blood; 2012 Mar; 119(10):2284-92. PubMed ID: 22234694
[TBL] [Abstract][Full Text] [Related]
4. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.
Tel J; Schreibelt G; Sittig SP; Mathan TS; Buschow SI; Cruz LJ; Lambeck AJ; Figdor CG; de Vries IJ
Blood; 2013 Jan; 121(3):459-67. PubMed ID: 23212525
[TBL] [Abstract][Full Text] [Related]
5. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
[TBL] [Abstract][Full Text] [Related]
6. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.
Cohn L; Chatterjee B; Esselborn F; Smed-Sörensen A; Nakamura N; Chalouni C; Lee BC; Vandlen R; Keler T; Lauer P; Brockstedt D; Mellman I; Delamarre L
J Exp Med; 2013 May; 210(5):1049-63. PubMed ID: 23569326
[TBL] [Abstract][Full Text] [Related]
7. CD141⁺ myeloid dendritic cells are enriched in healthy human liver.
Kelly A; Fahey R; Fletcher JM; Keogh C; Carroll AG; Siddachari R; Geoghegan J; Hegarty JE; Ryan EJ; O'Farrelly C
J Hepatol; 2014 Jan; 60(1):135-42. PubMed ID: 23968887
[TBL] [Abstract][Full Text] [Related]
8. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.
Bachem A; Güttler S; Hartung E; Ebstein F; Schaefer M; Tannert A; Salama A; Movassaghi K; Opitz C; Mages HW; Henn V; Kloetzel PM; Gurka S; Kroczek RA
J Exp Med; 2010 Jun; 207(6):1273-81. PubMed ID: 20479115
[TBL] [Abstract][Full Text] [Related]
9. Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation.
Sluijter BJ; van den Hout MF; Koster BD; van Leeuwen PA; Schneiders FL; van de Ven R; Molenkamp BG; Vosslamber S; Verweij CL; van den Tol MP; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Cancer Immunol Res; 2015 May; 3(5):495-505. PubMed ID: 25633713
[TBL] [Abstract][Full Text] [Related]
10. Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets.
Chiang MC; Tullett KM; Lee YS; Idris A; Ding Y; McDonald KJ; Kassianos A; Leal Rojas IM; Jeet V; Lahoud MH; Radford KJ
Eur J Immunol; 2016 Feb; 46(2):329-39. PubMed ID: 26542182
[TBL] [Abstract][Full Text] [Related]
11. BDCA3(+)CLEC9A(+) human dendritic cell function and development.
van der Aa E; van Montfoort N; Woltman AM
Semin Cell Dev Biol; 2015 May; 41():39-48. PubMed ID: 24910448
[TBL] [Abstract][Full Text] [Related]
12. Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141
Huang J; Zhou J; Ghinnagow R; Seki T; Iketani S; Soulard D; Paczkowski P; Tsuji Y; MacKay S; Cruz LJ; Trottein F; Tsuji M
Front Immunol; 2020; 11():2043. PubMed ID: 32973811
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Wyss T; Inoges S; de Vries IJM; Dartiguenave F; Jichlinski P; Derrè L; Coukos G; Melero I; Harari A; Romero P; Viganó S; Kandalaft LE
Eur J Cancer; 2020 Aug; 135():173-182. PubMed ID: 32590296
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
Balan S; Dalod M
Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
[TBL] [Abstract][Full Text] [Related]
15. Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.
Kassianos AJ; Wang X; Sampangi S; Muczynski K; Healy H; Wilkinson R
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1391-401. PubMed ID: 24049150
[TBL] [Abstract][Full Text] [Related]
16. Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man.
Brown FF; Campbell JP; Wadley AJ; Fisher JP; Aldred S; Turner JE
Physiol Behav; 2018 Oct; 194():191-198. PubMed ID: 29763678
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.
Sittig SP; Bakdash G; Weiden J; Sköld AE; Tel J; Figdor CG; de Vries IJ; Schreibelt G
Mediators Inflamm; 2016; 2016():3605643. PubMed ID: 27057096
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
Cooles FAH; Anderson AE; Skelton A; Pratt AG; Kurowska-Stolarska MS; McInnes I; Hilkens CMU; Isaacs JD
Front Immunol; 2018; 9():755. PubMed ID: 29867920
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
20. [Specialized dendritic cells in cross-presentation of exogenous antigens to cytotoxic T lymphocytes].
Alfaro C; Oñate C; Rodríguez A; Pérez-Gracia JL; Fernández de Sanmamed M; Melero I
An Sist Sanit Navar; 2013; 36(3):519-37. PubMed ID: 24406364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
